Cardiol Therapeutics Inc T.CRDL

Alternate Symbol(s): CRDL

Healthcare

Cardiol Therapeutics Inc. is a clinical-stage life sciences company. The Company is focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. Its lead drug candidate, CardiolRx (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease. It is recognized that cannabidiol inhibits activation of the inflammasome pathway, an intracellular process known to play an important role in the development and progression of inflammation and fibrosis associated with myocarditis, pericarditis, and heart failure. It is also developing CRD-38, a novel subcutaneously administered drug intended for use in heart failure. It has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart.

TSX:CRDL - Post by User

Cardiol Therapeutics Inc > A slow and steady climb to $10

<< Previous

Bullboard Posts

Next >>

Comment by Youhillmanon Oct 03, 2021 9:16pm

190 Views

Post# 33959439

RE:RE:A slow and steady climb to $10

OMG....so good to hear from Mapleleaf57 after the run CRDL had over the past 7 weeks, I mean the SP more than doubled during that time period.

Mapleleaf57...some profit taking is the reason for the short term decline, something you wouldn't have experienced like all the other CRDL holders did!

FDA approval in Q1 2022 will take the SP over $20....something Maplelaugh57 won't be part of!

Be long on CRDL!